I Got 99 Problems but Product vs. Platform ain’t one: Introducing Microbes-as-a-Service
By Moji Karimi, CEO, Cemvita Factory Special to The Digest Any SynBio (synthetic biology) company is faced with three principal questions right off the bat: 1. Product or platform? A) Product: develop the microbe, build the plant, and sell the product. The end molecule is the revenue source B) Platform: develop the microbe and commercialize […]











